The Health Research Board
Improving health and solving societal challenges through excellent research, data and evidence.
Learn more about who we are and what we doDoes social media influence teens to vape?
Yes is the answer according to research conducted by transition year student Leah Nolan from Loretto Secondary School Cork. The finding came as part of her winning entry into this year’s BT Young Scientist Exhibition.
HRB to develop Ireland’s first mental health research and evaluation strategy
This new strategy is a HRB-led deliverable under the national mental health policy Sharing the Vision – A Mental Health Policy for Everyone 2020 – 2030.
Health Research in Action 2021
The latest edition of this annual publication provides another lively snapshot of the powerful and wide-ranging impact that HRB and HRB-funded research is having on health and social care in Ireland.
Seven new Applied Partnership Awards
Children’s palliative care, stroke patients and women with epilepsy are among the groups who will benefit from this €1.3 million investment.
New €12 million Applied Programme Grant scheme
A pre announcement to help interested applicants to prepare ahead of the call going live
Can personalised medicine transform healthcare in Ireland?
Upcoming HRB conference will explore what personalised medicine means, the promise it offers for people and our health system, and the challenges of making it a reality.
HRB supports Genomic Data Infrastructure (GDI) in Ireland
HRB to invest €400,000 to co-fund Irish participation in a €40m Federated European infrastructure for genomics data under the Digital Europe Programme.
New HRB report reviews health effects of community water fluoridation
The Health Research Board (HRB) has published an in-depth evidence review of existing research in relation to the health effects of community water fluoridation, finding no definitive evidence of negative health effects.
New HRB evidence review examines service user participation in drug services
Our latest review gives a comprehensive overview of research on service user participation in the design and delivery of drug treatment, recovery and harm reduction services – aiming to provide policy and practice with a clearer understanding of the role of user involvement in developing more effective services.
HRB report shows a decline in problem opioid use among younger age groups
The latest HRB study presents a comprehensive picture of problem opioid use in Ireland.
HRB reports a continued rise in psychiatric admissions related to eating disorders among young people
The latest HRB figures from the National Psychiatric Inpatient Reporting System (NPIRS) highlight a gradual return to pre-COVID numbers for psychiatric in-patient admissions in 2021, and a rise in the number of admissions related to eating disorders among children and adolescents.
HRB publishes Annual Report 2021
This report highlights key HRB achievements during 2021 as aligned to the objectives of our 2025 Strategy (Health research - making an impact), showcasing examples of significant outcomes and successes.
HRB invests €10 million to address emerging health challenges
The Investigator-Led Projects (ILP) 2022 scheme will support high-quality research in important areas including schizophrenia, antimicrobial resistance, and elderly care in hospitals.
HRB invests €1.8 million in Ireland’s health research charities
Investment in the Health Research Board-Health Research Charities Ireland (HRB-HRCI) Joint Funding Scheme will benefit charities including the Irish Cancer Society and Fighting Blindness.
New European survey sheds light on how Irish people are using drugs
The Health Research Board (HRB) has published the Irish results from the European Web Survey on Drugs (EWSD), providing insights into the behaviour of a wide range of people who use drugs.
HRB invests €7 million in a new generation of researchers
Health inequality, schizophrenia, and therapies in children with cystic fibrosis are three of nine important topics to be addressed by our Emerging Investigator Awards for Health (EIA) 2022.
HRB releases 2021 alcohol treatment data
A total of 50,304 cases were treated for problem alcohol use in Ireland between 2015 and 2021, according to the latest figures published by the HRB in the 2021 report on data from the National Drug Treatment Reporting System.
Irish health researchers secure highest ever annual EU funding
Irish health researchers have secured just over €29.2 million from the first round of funding in Horizon Europe, the EU Framework Programme for Research and Innovation.
Drug treatment trends in focus of latest HRB report
New figures from the Health Research Board show continued growth in the number of cases seeking treatment for problem cocaine use, with cocaine overtaking heroin as the main problem drug among cases reported to the HRB.
New HRB report examines substance use among young people
The latest HRB report presents recent information on 15-24-year-olds’ use of alcohol and other drugs, the associated harms and the measures that are being taken to protect children from the effects of early substance use.
HRB-TMRN announces scientists of tomorrow
Three primary schools were shortlisted as finalists in the annual START competition, which is run by the Health Research Board-Trials Methodology Research Network (HRB-TMRN).
New HRB evidence review spotlights workplace health and wellbeing
The latest evidence review conducted by the Health Research Board identifies key factors in improving overall wellbeing and health outcomes in the workplace.
ICTD 2022
As we mark International Clinical Trials Day (ICTD) 2022, we give an overview of our €155 million investment to develop a world class clinical trials ecosystem for Ireland.
HRB supports Ukraine
Our Ucrisis 2022 funding call will support Ukrainian researchers impacted by the Russian invasion.
HRB awards €11 million to train Ireland’s future clinical academic leaders
The ICAT 2 programme will equip clinical academics and clinician scientists across the island of Ireland to address the challenges of an evolving global health agenda.
HRB invests €1 million in Rare Disease Clinical Trial Network
The announcement comes on Rare Disease Day 2022, and positions Ireland as a world leader in rare disease research and clinical trials.
